View Future GrowthMedservRegis 과거 순이익 실적과거 기준 점검 5/6MedservRegis은 연평균 74.2%의 비율로 수입이 증가해 온 반면, Energy Services 산업은 수입이 47.6% 증가했습니다. 매출은 연평균 26.7%의 비율로 증가했습니다. MedservRegis의 자기자본이익률은 9.4%이고 순이익률은 5%입니다.핵심 정보74.24%순이익 성장률73.41%주당순이익(EPS) 성장률Energy Services 산업 성장률23.29%매출 성장률26.75%자기자본이익률9.41%순이익률4.96%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트공시 • Apr 14MedservRegis p.l.c. to Report Fiscal Year 2025 Results on Apr 28, 2026MedservRegis p.l.c. announced that they will report fiscal year 2025 results at 9:32 AM, Central European Standard Time on Apr 28, 2026공시 • Jun 27MedservRegis p.l.c. to Report First Half, 2025 Results on Aug 29, 2025MedservRegis p.l.c. announced that they will report first half, 2025 results on Aug 29, 2025Reported Earnings • Jun 28Full year 2022 earnings releasedFull year 2022 results: Revenue: €66.9m (up 124% from FY 2021). Net income: €545.0k (up €8.16m from FY 2021). Profit margin: 0.8% (up from net loss in FY 2021).Reported Earnings • Aug 30First half 2022 earnings released: €0.012 loss per share (vs €0.011 profit in 1H 2021)First half 2022 results: €0.012 loss per share (down from €0.011 profit in 1H 2021). Revenue: €26.1m (up 410% from 1H 2021). Net loss: €1.17m (down 295% from profit in 1H 2021).모든 업데이트 보기Recent updatesBoard Change • Jun 02Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • May 21Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Apr 14MedservRegis p.l.c. to Report Fiscal Year 2025 Results on Apr 28, 2026MedservRegis p.l.c. announced that they will report fiscal year 2025 results at 9:32 AM, Central European Standard Time on Apr 28, 2026공시 • Mar 31MedservRegis p.l.c., Annual General Meeting, May 27, 2026MedservRegis p.l.c., Annual General Meeting, May 27, 2026.분석 기사 • Nov 04Investors Still Aren't Entirely Convinced By MedservRegis p.l.c.'s (MTSE:MDS) Revenues Despite 38% Price JumpMedservRegis p.l.c. ( MTSE:MDS ) shares have had a really impressive month, gaining 38% after a shaky period...분석 기사 • Oct 26Is MedservRegis (MTSE:MDS) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...분석 기사 • Sep 20Market Might Still Lack Some Conviction On MedservRegis p.l.c. (MTSE:MDS) Even After 30% Share Price BoostMedservRegis p.l.c. ( MTSE:MDS ) shareholders would be excited to see that the share price has had a great month...공시 • Jun 27MedservRegis p.l.c. to Report First Half, 2025 Results on Aug 29, 2025MedservRegis p.l.c. announced that they will report first half, 2025 results on Aug 29, 2025분석 기사 • May 22We Think Some Shareholders May Hesitate To Increase MedservRegis p.l.c.'s (MTSE:MDS) CEO CompensationKey Insights MedservRegis' Annual General Meeting to take place on 29th of May Total pay for CEO David O’Connor...공시 • Apr 23Medservregis P.L.C. Recommends Further Gross Dividend, Payable by No Later Than June 30, 2025MedservRegis p.l.c. Board of Directors recommended the payment of a further gross dividend for the year under review of €1.5 million, equivalent to a gross dividend of €0.014758 per share (net €0.014221 per share1), on all shares settled as at close of business on the 13 May 2025, which dividend shall be paid by no later than 30 June 2025.공시 • Mar 19MedservRegis p.l.c., Annual General Meeting, May 29, 2025MedservRegis p.l.c., Annual General Meeting, May 29, 2025.분석 기사 • Feb 26MedservRegis p.l.c. (MTSE:MDS) Stock's 26% Dive Might Signal An Opportunity But It Requires Some ScrutinyTo the annoyance of some shareholders, MedservRegis p.l.c. ( MTSE:MDS ) shares are down a considerable 26% in the last...분석 기사 • Jan 20Estimating The Fair Value Of MedservRegis p.l.c. (MTSE:MDS)Key Insights Using the 2 Stage Free Cash Flow to Equity, MedservRegis fair value estimate is €0.43 MedservRegis' €0.50...분석 기사 • Nov 28Investors Still Aren't Entirely Convinced By MedservRegis p.l.c.'s (MTSE:MDS) Revenues Despite 32% Price JumpDespite an already strong run, MedservRegis p.l.c. ( MTSE:MDS ) shares have been powering on, with a gain of 32% in the...분석 기사 • Nov 22Does MedservRegis (MTSE:MDS) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Board Change • Oct 07Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Aug 05Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • May 28Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Apr 20Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Mar 27Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.New Risk • Mar 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 15% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€72.2m market cap, or US$78.6m).Board Change • Mar 08Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.공시 • Feb 03MedservRegis p.l.c. Provides Earnings Guidance for the Year Ended December 31, 2023MedservRegis p.l.c. provided earnings guidance for the year ended December 31, 2023. The group's unaudited revenues for 2023 are anticipated to be in the region of EUR 73 million, an increase of 9% compared to the EUR 66.9 million achieved in 2022 and an increase of 13.2% against the revenue forecast disclosed in the 2022 Updated Financial Analysis Summary.분석 기사 • Jan 24MedservRegis p.l.c. (MTSE:MDS) Doing What It Can To Lift SharesIt's not a stretch to say that MedservRegis p.l.c.'s ( MTSE:MDS ) price-to-sales (or "P/S") ratio of 1x right now seems...Board Change • Jan 23Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Nov 01Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Emerging Markets & Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Jul 20Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Reported Earnings • Jun 28Full year 2022 earnings releasedFull year 2022 results: Revenue: €66.9m (up 124% from FY 2021). Net income: €545.0k (up €8.16m from FY 2021). Profit margin: 0.8% (up from net loss in FY 2021).Board Change • Jun 15Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Feb 02Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Dec 22Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Nov 22Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Oct 21Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Reported Earnings • Aug 30First half 2022 earnings released: €0.012 loss per share (vs €0.011 profit in 1H 2021)First half 2022 results: €0.012 loss per share (down from €0.011 profit in 1H 2021). Revenue: €26.1m (up 410% from 1H 2021). Net loss: €1.17m (down 295% from profit in 1H 2021).Board Change • Aug 24Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Aug 02Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.Board Change • Jun 21Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Jun 17MedservRegis p.l.c., Annual General Meeting, Jul 28, 2022MedservRegis p.l.c., Annual General Meeting, Jul 28, 2022. Agenda: To consider approval of the annual report 2021.Board Change • Mar 04Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Feb 03Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Jan 19Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Board Change • Jan 06Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.매출 및 비용 세부 내역MedservRegis가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이MTSE:MDS 매출, 비용 및 순이익 (EUR Millions)날짜매출순이익일반관리비연구개발비31 Dec 25105519030 Sep 2594518030 Jun 2582516031 Mar 2576315031 Dec 2470213030 Sep 2472114030 Jun 2474014031 Mar 2474013031 Dec 2374112030 Sep 2373212030 Jun 2373312031 Mar 2370213031 Dec 2267114030 Sep 2258-512030 Jun 2250-1011031 Mar 2240-910031 Dec 2130-89030 Jun 2111-98031 Mar 2111-98031 Dec 2011-128030 Sep 2014-107030 Jun 2016-99031 Mar 2018-107031 Dec 1919-78030 Sep 191918030 Jun 191847031 Mar 191957031 Dec 181766031 Dec 171505031 Dec 162484031 Dec 15521660양질의 수익: MDS는 고품질 수익을 보유하고 있습니다.이익 마진 증가: MDS의 현재 순 이익률 (5%)은 지난해 (2.7%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: MDS는 지난 5년 동안 흑자전환하며 연평균 74.2%의 수익 성장을 기록했습니다.성장 가속화: 지난 1년간 MDS 의 수익 증가율(177.7%)은 연간 평균(74.2%)을 초과합니다.수익 대 산업: MDS의 지난 1년 수익 증가율(177.7%)은 Energy Services 업계의 30%를 상회했습니다.자기자본이익률높은 ROE: MDS의 자본 수익률(9.4%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YEnergy 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/12 04:23종가2026/06/03 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스MedservRegis p.l.c.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Apr 14MedservRegis p.l.c. to Report Fiscal Year 2025 Results on Apr 28, 2026MedservRegis p.l.c. announced that they will report fiscal year 2025 results at 9:32 AM, Central European Standard Time on Apr 28, 2026
공시 • Jun 27MedservRegis p.l.c. to Report First Half, 2025 Results on Aug 29, 2025MedservRegis p.l.c. announced that they will report first half, 2025 results on Aug 29, 2025
Reported Earnings • Jun 28Full year 2022 earnings releasedFull year 2022 results: Revenue: €66.9m (up 124% from FY 2021). Net income: €545.0k (up €8.16m from FY 2021). Profit margin: 0.8% (up from net loss in FY 2021).
Reported Earnings • Aug 30First half 2022 earnings released: €0.012 loss per share (vs €0.011 profit in 1H 2021)First half 2022 results: €0.012 loss per share (down from €0.011 profit in 1H 2021). Revenue: €26.1m (up 410% from 1H 2021). Net loss: €1.17m (down 295% from profit in 1H 2021).
Board Change • Jun 02Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • May 21Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Apr 14MedservRegis p.l.c. to Report Fiscal Year 2025 Results on Apr 28, 2026MedservRegis p.l.c. announced that they will report fiscal year 2025 results at 9:32 AM, Central European Standard Time on Apr 28, 2026
공시 • Mar 31MedservRegis p.l.c., Annual General Meeting, May 27, 2026MedservRegis p.l.c., Annual General Meeting, May 27, 2026.
분석 기사 • Nov 04Investors Still Aren't Entirely Convinced By MedservRegis p.l.c.'s (MTSE:MDS) Revenues Despite 38% Price JumpMedservRegis p.l.c. ( MTSE:MDS ) shares have had a really impressive month, gaining 38% after a shaky period...
분석 기사 • Oct 26Is MedservRegis (MTSE:MDS) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
분석 기사 • Sep 20Market Might Still Lack Some Conviction On MedservRegis p.l.c. (MTSE:MDS) Even After 30% Share Price BoostMedservRegis p.l.c. ( MTSE:MDS ) shareholders would be excited to see that the share price has had a great month...
공시 • Jun 27MedservRegis p.l.c. to Report First Half, 2025 Results on Aug 29, 2025MedservRegis p.l.c. announced that they will report first half, 2025 results on Aug 29, 2025
분석 기사 • May 22We Think Some Shareholders May Hesitate To Increase MedservRegis p.l.c.'s (MTSE:MDS) CEO CompensationKey Insights MedservRegis' Annual General Meeting to take place on 29th of May Total pay for CEO David O’Connor...
공시 • Apr 23Medservregis P.L.C. Recommends Further Gross Dividend, Payable by No Later Than June 30, 2025MedservRegis p.l.c. Board of Directors recommended the payment of a further gross dividend for the year under review of €1.5 million, equivalent to a gross dividend of €0.014758 per share (net €0.014221 per share1), on all shares settled as at close of business on the 13 May 2025, which dividend shall be paid by no later than 30 June 2025.
공시 • Mar 19MedservRegis p.l.c., Annual General Meeting, May 29, 2025MedservRegis p.l.c., Annual General Meeting, May 29, 2025.
분석 기사 • Feb 26MedservRegis p.l.c. (MTSE:MDS) Stock's 26% Dive Might Signal An Opportunity But It Requires Some ScrutinyTo the annoyance of some shareholders, MedservRegis p.l.c. ( MTSE:MDS ) shares are down a considerable 26% in the last...
분석 기사 • Jan 20Estimating The Fair Value Of MedservRegis p.l.c. (MTSE:MDS)Key Insights Using the 2 Stage Free Cash Flow to Equity, MedservRegis fair value estimate is €0.43 MedservRegis' €0.50...
분석 기사 • Nov 28Investors Still Aren't Entirely Convinced By MedservRegis p.l.c.'s (MTSE:MDS) Revenues Despite 32% Price JumpDespite an already strong run, MedservRegis p.l.c. ( MTSE:MDS ) shares have been powering on, with a gain of 32% in the...
분석 기사 • Nov 22Does MedservRegis (MTSE:MDS) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Board Change • Oct 07Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Aug 05Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • May 28Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Apr 20Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Mar 27Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean-Pierre Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
New Risk • Mar 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 15% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Market cap is less than US$100m (€72.2m market cap, or US$78.6m).
Board Change • Mar 08Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
공시 • Feb 03MedservRegis p.l.c. Provides Earnings Guidance for the Year Ended December 31, 2023MedservRegis p.l.c. provided earnings guidance for the year ended December 31, 2023. The group's unaudited revenues for 2023 are anticipated to be in the region of EUR 73 million, an increase of 9% compared to the EUR 66.9 million achieved in 2022 and an increase of 13.2% against the revenue forecast disclosed in the 2022 Updated Financial Analysis Summary.
분석 기사 • Jan 24MedservRegis p.l.c. (MTSE:MDS) Doing What It Can To Lift SharesIt's not a stretch to say that MedservRegis p.l.c.'s ( MTSE:MDS ) price-to-sales (or "P/S") ratio of 1x right now seems...
Board Change • Jan 23Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Nov 01Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Group Deputy CEO of Emerging Markets & Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Jul 20Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Deputy CEO of Business & Operations and Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Jean Lhote was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Reported Earnings • Jun 28Full year 2022 earnings releasedFull year 2022 results: Revenue: €66.9m (up 124% from FY 2021). Net income: €545.0k (up €8.16m from FY 2021). Profit margin: 0.8% (up from net loss in FY 2021).
Board Change • Jun 15Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Feb 02Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Dec 22Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Nov 22Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Oct 21Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Reported Earnings • Aug 30First half 2022 earnings released: €0.012 loss per share (vs €0.011 profit in 1H 2021)First half 2022 results: €0.012 loss per share (down from €0.011 profit in 1H 2021). Revenue: €26.1m (up 410% from 1H 2021). Net loss: €1.17m (down 295% from profit in 1H 2021).
Board Change • Aug 24Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Aug 02Less than half of directors are independentThere are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 8 new directors. No experienced directors. No highly experienced directors. 3 independent directors (5 non-independent directors). Executive Director Karl Bartolo is the most experienced director on the board, commencing their role in 2021. Non-Executive Independent Director Monica Oliveira-Vilabril was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors.
Board Change • Jun 21Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Jun 17MedservRegis p.l.c., Annual General Meeting, Jul 28, 2022MedservRegis p.l.c., Annual General Meeting, Jul 28, 2022. Agenda: To consider approval of the annual report 2021.
Board Change • Mar 04Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Feb 03Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Jan 19Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Board Change • Jan 06Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. 2 independent directors (4 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.